REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
01/19/2026
Back to search
Official data from USPTO
EVERZOM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
01/20/2026
Trademark type
Word
Nice classes
42, 44
Filing date
03/04/2020
Registration date
01/19/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/19/2021
Last transaction
01/20/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
FR
Examiner
TULLY, MATTHEW
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
EVERZOM
Representatives
Arnaud Rainfray O'Brien Barristers and Sollicitors
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Medical research and pharmacological research services; analysis of human tissues for medical research purposes; pharmaceutical drug development servicesdevelopment of pharmaceutical preparations and medicines from extracellular vesicles; conducting clinical trials for others; provision of information in connection with medical and scientific research in the field of pharmaceutical products and clinical trials; medical research and laboratory services in the field of human tissuetissue engineering; medical research servicesclinical research in the field of biotherapy; conducting clinical trials for otherscarrying out clinical trials for pharmaceutical products; testing on pharmaceutical products; quality control for othersquality evaluation of pharmaceutical products; research and development in the field of pharmaceuticals and biotechnology; medical research servicesbiologicalclinical and medical research services in the field of biotherapy; scientific research for medical purposes in the field of biotherapy; scientific research in the field of extracellular vesiclesscientific research in the field of analysisisolation and production of extracellular vesicles; laboratory research services concerning pharmaceutical products; stem cell research; scientific research and development in the field of microorganisms and cells; scientific research and development in the field of extracellular vesicles; scientific research services with respect to the isolation and cultivation of human cells and tissues
Class 44
Medical servicesregenerative medicine services using extracellular vesicles; stem cell therapy servicestherapy services based on stem cells; biotherapy serviceshealth care therapy services for treating cancercardiovascular diseasesacute kidney injurybrain injuryliver injuryosteoarthrisisbone regenerationlung injurycutaneous wound healingfistulastenosisradio induced fibrosisautoimmune diseaseslysosomal storage disordersdegenerative diseasesusing extracellular vesicles; biotherapy servicesmedical services relating to the collectiontreatment and processing of human cells
Publications
History of USPTO decisions and trademark events.
27 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/24/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/16/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/23/2021
FIMP
FINAL DISPOSITION PROCESSED
04/23/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/19/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
01/19/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/03/2020
PUBO
PUBLISHED FOR OPPOSITION
11/03/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/14/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/28/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
09/28/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/28/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
09/28/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/28/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/09/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/08/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/08/2020
RFNT
REFUSAL PROCESSED BY IB
07/18/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/01/2020
RFRR
REFUSAL PROCESSED BY MPU
06/30/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/31/2020
CNRT
NON-FINAL ACTION WRITTEN
05/30/2020
DOCK
ASSIGNED TO EXAMINER
05/21/2020
MAFR
APPLICATION FILING RECEIPT MAILED
05/05/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/01/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/30/2020
Continuous trademark protection
Get notified about every new filing that threatens EVERZOM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.